You have 9 free searches left this month | for more free features.

Advanced, recurrent, or metastatic solid tumors of any type

Showing 9976 - 10000 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Biliary Tract Tumors, Immunotherapy Trial in Beijing (Durvalumab, Lenvatinib Oral Product, Chemotherapy)

Recruiting
  • Biliary Tract Neoplasms
  • Immunotherapy
  • Beijing, Beijing, China
    Chinese Academy of Medical Sciences & Peking Union Medical Colle
Jul 6, 2023

BPPV, Benign Paroxysmal Positional Vertigo, Vertigo Trial (vitamin D +/- calcium, Placebo)

Not yet recruiting
  • BPPV
  • +7 more
  • vitamin D +/- calcium
  • Placebo
  • (no location specified)
May 8, 2023

Locally Advanced Malignant Tumor, Rectal Carcinoma Trial in France (drug, other, radiation, procedure)

Recruiting
  • Locally Advanced Malignant Neoplasm
  • Rectal Carcinoma
  • Induction chemotherapy - modified FOLFIRINOX regimen
  • +3 more
  • Besançon, Doubs, France
  • +18 more
Jan 2, 2022

Colorectal Cancers With Microsatellite Instability

Active, not recruiting
  • Colorectal Cancer
  • Microsatellite Instability
    • Poitiers, Vienne, France
    • +13 more
    Aug 19, 2022

    Intrapulmonary Lymph Nodes in NSCLC and Visceral Pleural

    Recruiting
    • Lung Cancer
    • Lymph Node Metastasis
      • Lucerne, Switzerland
        Kantonsspital Luzern
      Jan 5, 2023

      Recurrent Pterygium, Micro-Conjunctival Autografting Combined With Amniotic Membrane Transplantation Trial in Nanchang

      Completed
      • Recurrent Pterygium
      • Micro-Conjunctival Autografting Combined With Amniotic Membrane Transplantation
      • Micro-Conjunctival Autograft Combined with Amniotic Membrane Transplantation
      • Conventional Autologous Conjunctival Transplantation
      • Nanchang, Jiangxi, China
        the Second Affiliated Hospital of Nanchang University
      May 3, 2022

      Ovarian Clear Cell Carcinoma Trial (Camrelizumab)

      Not yet recruiting
      • Ovarian Clear Cell Carcinoma
      • (no location specified)
      Oct 29, 2022

      Type1diabetes Trial in Boston (Very low carbohydrate diet, Standard carbohydrate diet)

      Recruiting
      • Type1diabetes
      • Very low carbohydrate diet
      • Standard carbohydrate diet
      • Boston, Massachusetts
        Boston Children's Hospital
      Nov 2, 2021

      Neurofibroma, Neurofibroma, Plexiform Trial (Cryotherapy)

      Not yet recruiting
      • Neurofibroma
      • Neurofibroma, Plexiform
      • Cryotherapy
      • (no location specified)
      Jan 19, 2022

      Tumors, Melanoma, Colorectal Tumor Trial in United States (ASN003 ascending doses, ASN003 MTD)

      Terminated
      • Neoplasms
      • +3 more
      • ASN003 ascending doses
      • ASN003 MTD
      • Los Angeles, California
      • +4 more
      May 17, 2019

      Participants Previously Treated With Century Therapeutics

      Not yet recruiting
      • Hematological Malignancy
      • Solid Tumor Malignancy
      • No Intervention
      • (no location specified)
      Mar 3, 2023

      Nasopharyngeal Carcinoma, De-escaltion Therapy Trial in Guangzhou (Reduced-target resection, Full-target resection, Adjuvant

      Recruiting
      • Nasopharyngeal Carcinoma
      • De-escaltion Therapy
      • Reduced-target resection
      • +2 more
      • Guangzhou, Guangdong, China
        Department of Nasopharyngeal Carcinoma, Sun Yat-sen University C
      May 25, 2023

      Unresectable, Non-metastatic Hepatocellular Carcinoma Trial in China (biological, drug, procedure)

      Recruiting
      • Unresectable, Non-metastatic Hepatocellular Carcinoma
      • AK104
      • +2 more
      • Beijing, Beijing, China
      • +4 more
      Aug 11, 2022

      Metastatic Pancreatic Ductal Adenocarcinoma Trial in Belgium, France, Spain (CD40 agonist mitazalimab in combination with chemo)

      Recruiting
      • Metastatic Pancreatic Ductal Adenocarcinoma
      • CD40 agonist mitazalimab in combination with chemotherapy
      • Brussels, Belgium
      • +15 more
      Aug 12, 2022

      Molecular Profiling in Guiding Individualized Treatment Plan in

      Completed
      • Adult Glioblastoma
      • specialized tumor board recommendation
      • San Francisco, California
        University of California, San Francisco
      Jul 26, 2020

      Type 1 Diabetes Trial in Wilmington, Jacksonville, Orlando (Usual Care, Transdisciplinary Care-In Person & Telehealth)

      Completed
      • Type 1 Diabetes Mellitus
      • Usual Care
      • Transdisciplinary Care-In Person & Telehealth
      • Wilmington, Delaware
      • +2 more
      Jul 8, 2022

      Melanoma Trial (ABP 206, FDA-licensed Nivolumab, EU-authorized Nivolumab)

      Not yet recruiting
      • Melanoma
      • ABP 206
      • +2 more
      • (no location specified)
      Jun 8, 2023

      Childhood CNS Tumor Trial in Washington (genetic, radiation, drug)

      Not yet recruiting
      • Childhood CNS Tumor
      • SGT-53
      • +4 more
      • Washington, District of Columbia
        Children's National Medical Center
      Feb 7, 2022

      Nutritional Deficiency and Recurrent Miscarriage

      Not yet recruiting
      • Recurrent Miscarriage
      • No intervention
      • Beijing, Beijing, China
        Peking Union Medical College Hospital, Peking Union Medical Coll
      Feb 23, 2022

      Periodontitis, Adult Trial in Cairo (advanced PRF)

      Completed
      • Periodontitis, Adult
      • advanced PRF
      • Cairo, Egypt
        Al-Azhar University, Faculty of Dentistry
      Feb 7, 2023

      Metastatic Epidural Spinal Cord Compression Trial in Houston (Stereotactic Radiosurgery (SSRS))

      Active, not recruiting
      • Metastatic Epidural Spinal Cord Compression
      • Stereotactic Radiosurgery (SSRS)
      • Houston, Texas
        University of Texas MD Anderson Cancer Center
      Oct 11, 2022

      Hypertrophy Trial (Krill oil, Krill protein, Vegetable oil)

      Not yet recruiting
      • Hypertrophy
      • Krill oil
      • +3 more
      • (no location specified)
      Mar 7, 2023

      Efficacy and Safety of Anlotinib for Advanced Non-small Cell

      Completed
      • NSCLC
        • Wuhan, Hubei, China
          Hubei province
        Oct 19, 2022

        Hepatocellular Carcinoma, Liver Cirrhosis Trial in New Delhi (Lenvatinib, Mebendazole, Placebo)

        Recruiting
        • Hepatocellular Carcinoma
        • Liver Cirrhosis
        • New Delhi, Delhi, India
          Institute of Liver & Biliary Sciences
        Oct 4, 2021

        Rotator Cuff Tears Trial (exercise program consisting of supervised exercise and physical activity, exercises program consisting

        Not yet recruiting
        • Rotator Cuff Tears
        • exercise program consisting of supervised exercise and physical activity
        • exercises program consisting of only supervised exercises.
        • (no location specified)
        Apr 6, 2023